ALKEM Ltd.

1958.15.00INR + 39.30 (+ 2.05%) VOLUME : 132000
    Average Volume
  • 5-Day 52,600.00
  • 20-Day 42,300.00
  • 3-Months 41,283.33

MARKET CLOSED

Price Table

Date Open High GREEN: if High is higher than last 2 days high
RED: if high is lower than last 2 days high
Low GREEN:if Low is higher than last 2 days low
RED: if low is lower than last 2 days low
LTP Close GREEN:if Day's Closing is near the Day's High
RED: if low is lower than last 2 days low
Volume Delivery % 20 Day SMA GREEN: if Day's Closing is above 20-Day SMA
RED: if Day's Closing is below 20-Day SMA
50 Day SMA GREEN: if Day's Closing is above 50-Day SMA
RED: if Day's Closing is below 50-Day SMA
100 Day SMA GREEN: if Day's Closing is above 100-Day SMA
RED: if Day's Closing is below 100-Day SMA
200 Day SMA GREEN: if Day's Closing is above 200-Day SMA
RED: if Day's Closing is below 200-Day SMA
18-Oct-19 1920.20 2027.90 1920.10 1958.15 1958.95 132,385 82% 1,926.69 1,844.27 1,800.45 1,801.47
17-Oct-19 1915.85 1926.80 1891.05 1909.00 1918.85 12,463 60% 1,923.55 1,839.40 1,797.77 1,800.95
16-Oct-19 1916.00 1937.95 1906.00 1920.00 1914.40 8,762 57% 1,919.54 1,835.86 1,795.51 1,800.62
15-Oct-19 1947.90 1950.00 1911.00 1922.00 1915.10 19,628 68% 1,916.81 1,832.78 1,793.57 1,800.38
14-Oct-19 1954.90 1959.90 1930.00 1931.40 1941.95 90,443 75% 1,913.04 1,830.27 1,791.34 1,800.14
11-Oct-19 1930.15 1961.00 1930.00 1949.00 1947.30 12,746 65% 1,907.37 1,827.74 1,788.79 1,799.80
10-Oct-19 1932.60 1950.00 1910.00 1932.00 1929.00 51,518 87% 1,902.39 1,825.10 1,786.45 1,799.45

Performance

Key Data

Day High Low Range

Time Lowest Highest
10 AM 1920.10 1948.45
11 AM 1920.10 1948.45
12 PM 1920.10 2027.90
1 PM 1920.10 2027.90
2 PM 1920.10 2027.90

Company Profile - ALKEM Ltd.

ALKEM

It was being incorporated as a private limited company ‘Alkem Laboratories Private Limited’ as on August 8, 1973, at Patna under the Companies Act, 1956 and subsequently became a deemed public limited company under section 43A(2) of Companies Act, 1956 on October 26, 1988. According to the Company passing a resolution under section 21 of Companies Act, 1956 and upon issuance of a fresh certificate of incorporation consequent on name change dated August 21, 2001, the company name was changed to ‘Alkem Laboratories Limited’ with effect from October 26, 1988. The registered office was initially located at ‘Exhibition Road, Patna – 800 001, Bihar, India’. The Company filed Company Petition No. 356(17)/ ERB/ 2007 before the Company Law Board, Eastern Region Bench at Kolkata for shifting the registered office of the Company from the State of Bihar to the State of Maharashtra, as approved by a special resolution at its extra-ordinary general meet ... ing held on January 29, 2007. The Company Law Board, Eastern Region Bench at Kolkata passed an order dated July 30, 2007, whereby it confirmed the alteration of the situation clause in the Memorandum of Association, from the State of Bihar to the State of Maharashtra. According to the order, the registered office of the Company was shifted to ‘Alkem House, Senapati Bapat Marg, Lower Parel, Mumbai – 400 013, Maharashtra, India’ with effect from August 2, 2007.

Some of the Milestones:

  • 1973: Incorporation of the Company took place.
  • 1978: It established its first plant at Taloja, Maharashtra.
  • 1988: It also became a deemed public limited company.
  • 1992: It also established its manufacturing facility in Mandwa, Maharashtra. This specific facility was converted into an API facility in 2005.
  • 1998: It established its Kachigam manufacturing facility in Gujarat.
  • 2001: Both Startronic Pharmachem Private Limited and Indo Propkem were being amalgamated with the Company.
  • 2002: It also established its Amaliya manufacturing facility in Gujarat.
  • 2003: It set up its research and development facility at Taloja, Maharashtra.
  • 2005: It established its manufacturing facility in Baddi, Himachal Pradesh.
  • 2006: Also, the anti-infective drug Taxim became the first drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India.
  • 2007:
  • It established its manufacturing facility located in Kumrek, Sikkim.
  • It filed its first ANDA in the United States for the drug, Amlodipine.
  • It shifted its Registered Office from Patna, Bihar to Mumbai, Maharashtra.
  • 2009: It acquired Pharmacor, a generic pharma company in Australia.
  • 2010: It also acquired The PharmaNetwork, LLC, which is the holding company of Ascend Laboratories LLC.
  • 2011: It also acquired Enzene Biosciences Limited.
  • 2012: It acquired an API manufacturing facility in the United States.
  • 2014: It also acquired the Clindac.
  • 2015: It also acquired a formulation manufacturing facility in the United States.
Some of the Achievements:
  • 2002: It was awarded the Pharma Business and Technology Excellence Award in 2002 as 'India’s Most Esteemed Pharmaceutical Company.'
  • 2004: Also, the product Taxim was awarded the Pharma Business and Technology Excellence Award for the successful brand in 2004.
  • 2005: It was awarded the Overall Performance Award for Group B at the 5th Express Pharma Awards in 2005.
  • 2009:
  • It received a certificate of appreciation for outstanding export performance in the category of formulations by the Pharmaceuticals Export Promotion Council of India, which is supported by the Ministry of Commerce and Industry, GOI.
  • It also received the certificate of appreciation in the category of ‘Formulation Experts’ by the Pharmaceuticals Export Promotion Council of India, supported by the Ministry of Commerce and Industry, GOI.
  • 2013: It was awarded India’s most admired pharma company award for 2013 during the 6th Annual Pharmaceutical Leadership Summit in 2013.
  • 2014: Its product ‘Clavam’ was awarded as the ‘Brand of the Year’ at the AWACS Award, 2014.
  • 2016: The Company's Mandva Plant successfully obtained the Establishment Inspection Report from the US FDA -Alkem receives EIR from the US FDA for its Daman formulation facility.